BDBM335738 1-(4-{4-[(1H-Pyrrolo[2,3-b]pyridin-5-ylmethyl)-amino]-pyrrolo[3,2-c]pyridin-1-ylmethyl}-benzyl)-1H-pyridin-2-one::US9738641, 3

SMILES O=c1ccccn1Cc1ccc(Cn2ccc3c(NCc4cnc5[nH]ccc5c4)nccc23)cc1

InChI Key InChIKey=KOTMMIHTHZXOHT-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 335738   

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM335738(1-(4-{4-[(1H-Pyrrolo[2,3-b]pyridin-5-ylmethyl)-ami...)
Affinity DataIC50: 5.46E+3nMAssay Description:Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
US Patent

TargetKallikrein-1(Human)
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM335738(1-(4-{4-[(1H-Pyrrolo[2,3-b]pyridin-5-ylmethyl)-ami...)
Affinity DataIC50: 5.69E+3nMAssay Description:KLK1 inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
US Patent